Umbilical Cord Blood and UC-MSCs Combined with Low-Dose Immunosuppressant in the Treatment of Elderly Patients with Pure Red Cell Aplastic: A Case Series.

Wei-Wei ZhuSujing ZhuangZhe YuXin LiTian-Jie HanYue MaLi-Jun LiZhi-Rui Zhao

Published in: Current stem cell research & therapy (2024)

This report provides an effective regimen of using UCB and UC-MSCs combined with low-dose CsA (1-3 mg/kg/d) to treat PRCA, especially for elderly patients with multiple complications who cannot use the conventional dosage.

Keyphrases

umbilical cord
low dose
mesenchymal stem cells
cell therapy
high dose
middle aged
community dwelling
single cell
bone marrow
risk factors
allogeneic hematopoietic stem cell transplantation
stem cells